login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
MINK THERAPEUTICS INC (INKT) Stock News
NASDAQ:INKT - Nasdaq -
US6036932019
-
Common Stock
- Currency: USD
19.5
+0.5 (+2.63%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
INKT Latest News, Press Relases and Analysis
All
Press Releases
8 days ago - By: Chartmill
- Mentions:
IKNA
AGRI
SXTP
BTCT
...
On Thursday, there are stocks with unusual volume. Let's take a look.
10 days ago - By: Chartmill
- Mentions:
GRO
CMBM
SQFT
ZEPP
...
Which stocks are moving on Tuesday?
10 days ago - By: Benzinga
- Mentions:
CYCC
SLP
SSII
LIXT
...
12 Health Care Stocks Moving In Tuesday's Intraday Session
10 days ago - By: Chartmill
- Mentions:
GRO
SLP
DDC
CMBM
...
Which stocks are moving on Tuesday?
10 days ago - By: Chartmill
- Mentions:
GRO
MSW
RAPT
SQFT
...
There are notable gap-ups and gap-downs in today's session.
10 days ago - By: MiNK Therapeutics
MiNK Therapeutics Announces Frontiers in Immunology Publication Highlighting iNKT Cells as a Dual-Function Platform Key to Overcoming Barriers in Solid Tumor Cell Therapy
10 days ago - By: MiNK Therapeutics
MiNK Therapeutics Announces Frontiers in Immunology Publication Highlighting iNKT Cells as a Dual-Function Platform Key to Overcoming Barriers in Solid Tumor Cell Therapy
11 days ago - By: Chartmill
- Mentions:
DDC
WKHS
CAN
SONN
...
These stocks are moving in today's session
11 days ago - By: Chartmill
- Mentions:
GAME
OCC
WKHS
ZEPP
...
Unusual volume stocks in Monday's session
11 days ago - By: Chartmill
- Mentions:
OCC
DDC
WKHS
CAN
...
Which stocks are moving on Monday?
11 days ago - By: Chartmill
- Mentions:
VBTX
WKHS
WINT
SNDL
...
Let's uncover which stocks are experiencing notable gaps during today's session.
11 days ago - By: Chartmill
- Mentions:
SQNS
WKHS
WINT
BQ
...
Monday's pre-market session: top gainers and losers
14 days ago - By: Chartmill
- Mentions:
RVSN
UBX
PASG
PUBM
...
What's going on in today's after hours session
14 days ago - By: MiNK Therapeutics
MiNK Therapeutics Announces Publication of Complete Remission Following Allogeneic iNKT Cell Therapy in Metastatic Testicular Cancer
14 days ago - By: MiNK Therapeutics
MiNK Therapeutics Announces Publication of Complete Remission Following Allogeneic iNKT Cell Therapy in Metastatic Testicular Cancer
a month ago - By: MiNK Therapeutics
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
a month ago - By: MiNK Therapeutics
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
2 months ago - By: MiNK Therapeutics
MiNK Therapeutics Awarded Prestigious NIAID Grant to Advance Allo-iNKT Cell Therapy for Prevention of GvHD in Stem Cell Transplant Patients
2 months ago - By: MiNK Therapeutics
MiNK Therapeutics Awarded Prestigious NIAID Grant to Advance Allo-iNKT Cell Therapy for Prevention of GvHD in Stem Cell Transplant Patients
2 months ago - By: MiNK Therapeutics
MiNK Therapeutics Reports Q1 2025 Results and Highlights Clinical & Strategic Progress
2 months ago - By: MiNK Therapeutics
MiNK Therapeutics Reports Q1 2025 Results and Highlights Clinical & Strategic Progress
2 months ago - By: Benzinga
A Look at MiNK Therapeutics's Upcoming Earnings Report
3 months ago - By: MiNK Therapeutics
MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report
3 months ago - By: MiNK Therapeutics
MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report
4 months ago - By: MiNK Therapeutics
MiNK Therapeutics Reports Fourth Quarter & Full Year 2024 Results and Highlights Business Progress
Please enable JavaScript to continue using this application.